299 related articles for article (PubMed ID: 7845667)
81. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
Giovannini M; Biegel JA; Serra M; Wang JY; Wei YH; Nycum L; Emanuel BS; Evans GA
J Clin Invest; 1994 Aug; 94(2):489-96. PubMed ID: 8040301
[TBL] [Abstract][Full Text] [Related]
82. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor.
Ida K; Kobayashi S; Taki T; Hanada R; Bessho F; Yamamori S; Sugimoto T; Ohki M; Hayashi Y
Int J Cancer; 1995 Nov; 63(4):500-4. PubMed ID: 7591257
[TBL] [Abstract][Full Text] [Related]
83. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.
Bertolotti A; Melot T; Acker J; Vigneron M; Delattre O; Tora L
Mol Cell Biol; 1998 Mar; 18(3):1489-97. PubMed ID: 9488465
[TBL] [Abstract][Full Text] [Related]
84. Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.
Spahn L; Petermann R; Siligan C; Schmid JA; Aryee DN; Kovar H
Cancer Res; 2002 Aug; 62(16):4583-7. PubMed ID: 12183411
[TBL] [Abstract][Full Text] [Related]
85. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
86. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.
Braunreiter CL; Hancock JD; Coffin CM; Boucher KM; Lessnick SL
Cell Cycle; 2006 Dec; 5(23):2753-9. PubMed ID: 17172842
[TBL] [Abstract][Full Text] [Related]
87. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo.
Aryee DN; Kreppel M; Bachmaier R; Uren A; Muehlbacher K; Wagner S; Breiteneder H; Ban J; Toretsky JA; Kovar H
Cancer Res; 2006 Oct; 66(20):9862-9. PubMed ID: 17047047
[TBL] [Abstract][Full Text] [Related]
88. The splicing factor U1C represses EWS/FLI-mediated transactivation.
Knoop LL; Baker SJ
J Biol Chem; 2000 Aug; 275(32):24865-71. PubMed ID: 10827180
[TBL] [Abstract][Full Text] [Related]
89. Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis.
Urano F; Umezawa A; Yabe H; Hong W; Yoshida K; Fujinaga K; Hata J
Jpn J Cancer Res; 1998 Jul; 89(7):703-11. PubMed ID: 9738976
[TBL] [Abstract][Full Text] [Related]
90. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
[TBL] [Abstract][Full Text] [Related]
91. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.
Zwerner JP; May WA
Oncogene; 2001 Feb; 20(5):626-33. PubMed ID: 11313995
[TBL] [Abstract][Full Text] [Related]
92. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma.
Urano F; Umezawa A; Hong W; Kikuchi H; Hata J
Biochem Biophys Res Commun; 1996 Feb; 219(2):608-12. PubMed ID: 8605035
[TBL] [Abstract][Full Text] [Related]
93. Co-regulated expression of dbl and poly(ADP-ribose) polymerase in Ewing's sarcoma cells and dbl-transformed NIH3T3 fibroblasts.
Velasco JA; Ramsamooj P; Thraves PJ; Eva A; Dritschilo A; Notario V
Oncogene; 1995 Jun; 10(11):2253-8. PubMed ID: 7784072
[TBL] [Abstract][Full Text] [Related]
94. Microsatellites are EWS/FLI response elements: genomic "junk" is EWS/FLI's treasure.
Gangwal K; Lessnick SL
Cell Cycle; 2008 Oct; 7(20):3127-32. PubMed ID: 18927503
[TBL] [Abstract][Full Text] [Related]
95. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.
Owen LA; Lessnick SL
Cell Cycle; 2006 Sep; 5(18):2049-53. PubMed ID: 16969112
[TBL] [Abstract][Full Text] [Related]
96. Microsatellites as EWS/FLI response elements in Ewing's sarcoma.
Gangwal K; Sankar S; Hollenhorst PC; Kinsey M; Haroldsen SC; Shah AA; Boucher KM; Watkins WS; Jorde LB; Graves BJ; Lessnick SL
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10149-54. PubMed ID: 18626011
[TBL] [Abstract][Full Text] [Related]
97. Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300.
Fuchs B; Inwards CY; Janknecht R
FEBS Lett; 2003 Oct; 553(1-2):104-8. PubMed ID: 14550555
[TBL] [Abstract][Full Text] [Related]
98. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).
Ichikawa H; Shimizu K; Katsu R; Ohki M
Mol Cell Biol; 1999 Nov; 19(11):7639-50. PubMed ID: 10523652
[TBL] [Abstract][Full Text] [Related]
99. Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman J; Melot T; Desmaze C; Ghysdael J; Plougastel B; Peter M; Zucker JM; Triche TJ; Sheer D; Turc-Carel C
EMBO J; 1993 Dec; 12(12):4481-7. PubMed ID: 8223458
[TBL] [Abstract][Full Text] [Related]
100. A method for accurate detection of translocation junctions in Ewing family of tumors.
Morishita T; Bolander ME; Zhang K; Tamai S; Mii Y; Sarkar G
Mol Biotechnol; 2001 Jun; 18(2):97-104. PubMed ID: 11471459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]